Home/Filings/4/0000905718-18-000015
4//SEC Filing

BACHA JEFFREY 4

Accession 0000905718-18-000015

CIK 0001498382other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:59 PM ET

Size

18.7 KB

Accession

0000905718-18-000015

Insider Transaction Report

Form 4
Period: 2017-12-22
BACHA JEFFREY
CEO and President10% Owner
Transactions
  • Other

    Common Stock

    2017-12-31$3.20/sh+176$56363,873 total
  • Award

    Options (Right to Buy)

    2017-12-22+87,50087,500 total
    Exercise: $4.20From: 2017-12-22Exp: 2020-12-31Common Stock (87,500 underlying)
  • Disposition to Issuer

    Options (Right to Buy)

    2017-12-2237,5000 total
    Exercise: $2.00Exp: 2022-02-01Common Stock (37,500 underlying)
  • Award

    Options (Right to Buy)

    2017-12-22+37,50037,500 total
    Exercise: $2.00From: 2017-12-22Exp: 2020-12-31Common Stock (37,500 underlying)
  • Disposition to Issuer

    Options (Right to Buy)

    2017-12-2287,5000 total
    Exercise: $4.20Exp: 2023-08-15Common Stock (87,500 underlying)
  • Disposition to Issuer

    Options (Right to Buy)

    2017-12-2293,6000 total
    Exercise: $4.95Exp: 2027-02-17Common Stock (93,600 underlying)
  • Award

    Options (Right to Buy)

    2017-12-22+93,60093,600 total
    Exercise: $4.95From: 2017-12-22Exp: 2020-12-31Common Stock (93,600 underlying)
Footnotes (2)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
  • [F2]Effective January 1, 2018, the Reporting Person's employment with the Issuer terminated. Pursuant to the terms of the Settlement Agreement dated December 22, 2017 between the Reporting Person and the Issuer, all of the Reporting Person's outstanding stock options became fully vested and exercisable on December 22, 2017, and terminate December 31, 2020. The Reporting Person shall continue to serve as a member of the board of directors. The six reported transactions in Table II disclose the deemed cancellation of "old" options and the grant of replacement options resulting from the foregoing amendments to the options.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001432149

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:59 PM ET
Size
18.7 KB